Skip to search formSkip to main contentSkip to account menu

RG7652

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Objective To evaluate the potential effects of proprotein convertase subtilisin/kexin type 9 monoclonal antibody (PCSK9-mAb) on… 
2017
2017
Proprotein convertase subtilisin/kexin type 9 (PCSK9) downregulates low‐density lipoprotein (LDL) receptors, thereby leading to a… 
2015
2015
ABSTRACTRG7652 is a fully humanized monoclonal antibody targeting human PCSK9, a regulator of serum low density lipoprotein… 
2014
2014
RG7652 is a human IgG1 monoclonal antibody designed to inhibit proprotein convertase subtilisin/kexin type 9 (PCSK9) binding to… 
2014
2014
RG7652 is a human immunoglobulin 1 (IgG1) monoclonal antibody (mAb) targeting proprotein convertase subtilisin/kexin type 9… 
Review
2013
Review
2013
Purpose: Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates hepatic LDL receptors, playing a key role in cholesterol… 
2013
2013
Background: RG7652 (MPSK3169A) is a fully human IgG1 monoclonal antibody (mAb) directed against proprotein convertase subtilisin… 
Review
2013
Review
2013
Objectives Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates hepatic LDL receptors, playing a key role in…